Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia-Reference-Cited by-同舟云学术

Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia

Published:2020-08 Issue:8 Volume:26 Page:1527-1533
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wright Rachel,Oremek Maximilian,Davies David,Kewley Caitlin,Singh Alyssa,Taitt Nathaniel,Kempshall Emma,Wilson Keith,Ingram Wendy

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference44 articles.

1. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group;Löwenburg;J Clin Oncol,1989

2. Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study;Reiffers;Leukemia,1996

3. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research;Lazarus;Br J Haematol,2006

4. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review;Oliansky;Biol Blood Marrow Transplant,2008

5. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome;McClune;J Clin Oncol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient concerns after haematopoietic stem cell transplantation: an evaluation;Cancer Nursing Practice;2024-02-14

2. Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment;Cancer Communications;2022-10-23

3. Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2022-04

4. Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies;Current Oncology Reports;2022-01

5. Changes in the health-related quality of life and social reintegration status after lung transplantation following hematopoietic stem cell transplantation;Supportive Care in Cancer;2021-10-05